1nhaler
1 known investors
1nhaler develops a single-dose dry powder inhaler made mostly from cardboard, designed to be low-cost, portable, propellant-free and low in carbon impact for delivering inhalable medicines. Its lead project is a salbutamol inhaler for asthma relief, with potential applications in rescue medications, anaphylaxis, migraine, vaccines and clinical trials.
Founders & leadership
HM
Helen MuirheadChief Scientific Officer
LL
Lars LarssonChief Medical Officer
Investors · 1
Frequently asked questions
- What does 1nhaler do?
- 1nhaler develops a single-dose dry powder inhaler made mostly from cardboard, designed to be low-cost, portable, propellant-free and low in carbon impact for delivering inhalable medicines. Its lead project is a salbutamol inhaler for asthma relief, with potential applications in rescue medications, anaphylaxis, migraine, vaccines and clinical trials.
- Who are 1nhaler's investors?
- 1nhaler's investors include Archangels.